Robert E. Haselow

1.1k citations
18 papers · 850 indexed · h-index 14

Impact in

Papers in

Robert E. Haselow

18 papers receiving 808 citations

Peers

Robert E. Haselow
Comparison fields: 5 of 60
  • Otorhinolaryngology 448
  • Oncology 296
  • Dermatology 79
  • Surgery 378
  • Genetics 87
Replace C.C. Wang with:
C.C. Wang United States
Paolo Potepan Italy
Jeffrey W. Bailet United States
Gözde Yazıcı Türkiye
Leonard J. Shukovsky United States
Edwin J. Liebner United States
T Elhakim Canada
C Jaulerry France
Iris Gluck Israel
Izumi Koike Japan
Robert E. Haselow relative to C.C. Wang United States C.C. Wang's profile →
Citations per field
00.5×10×15×21×
C.C. Wang · 1×
Citations per year

Countries citing papers authored by Robert E. Haselow

Since Specialization
Citations

This map shows the geographic impact of Robert E. Haselow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Haselow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Haselow more than expected).

Fields of papers citing papers by Robert E. Haselow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Haselow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Haselow. The network helps show where Robert E. Haselow may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert E. Haselow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert E. Haselow Line = papers co-authored together Robert E. Haselow links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 20167
2 2010114
3 201043
4 200014
5 199817
6 199623
7 199419
8 199325
9 199359
10 199222
11 1992303
12 19916
13 198549
14 19821
15 198116
16 198160
17 19805
18 197867

About Robert E. Haselow

Robert E. Haselow is a scholar working on Otorhinolaryngology, Radiation, Dermatology, Ophthalmology and Genetics, having authored 18 papers that have together received 850 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (7 papers), Advanced Radiotherapy Techniques (3 papers), Nonmelanoma Skin Cancer Studies (3 papers), Effects of Radiation Exposure (3 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers), Glioma Diagnosis and Treatment (2 papers), Ear and Head Tumors (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Otorhinolaryngology (448 citations), Oncology (296 citations), Dermatology (79 citations), Surgery (378 citations) and Genetics (87 citations). Robert E. Haselow has collaborated with scholars based in United States. Frequent co-authors include Thomas J. Ervin, James G. Schwade, George E. Laramore, Seymour H. Levitt, Muhyi Al‐Sarraf, Charles Scott, R. Gahbauer, Bruce H. Campbell, Dorit Elisabeth Schuller and Richard Wheeler. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Cancer, Journal of Clinical Oncology, Radiology and Human Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026